To test whether the observed up-regulation of DNMT1 expression in ALK tumor samples is associated with deregulation of cell cycle–associated genes, we performed Western blot analysis using antibodies against c-MYC, CDK4/CDK6, cyclin D1, and the proliferation marker PCNA (Fig 2H and I). The gene discussed is CDK6; the disease is neoplasm.